• 09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomes

  • Nov 27 2023
  • Length: 34 mins
  • Podcast

09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomes

Listen for free

View show details

  • Summary

  • In this two-part episode, Javier Bolaños-Meade, MD, with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Shernan Holtan, MD, with the University of Minnesota discuss advances and innovations in graft-versus-host disease (GVHD) prevention that call for a new standard of care in patients needing allogeneic hematopoietic cell transplantation.

    In Part I: PTCy and Improved Outcomes, experts highlight the history of GVHD prevention and the impacts of post-transplant cyclophosphamide (PTCy) in particular in improving outcomes and closing gaps in access to care.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    Show more Show less
activate_WEBCRO358_DT_T2
activate_samplebutton_t1
Physical Illness & Disease Hygiene & Healthy Living
Show more Show less

What listeners say about 09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomes

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.ca reviews

Amazon Reviews
No reviews are available